Profound Medical PROF Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Profound Medical in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.
The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Profound Medical's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Profound Medical's additional paid-in capital?
- Profound Medical (PROF) reported additional paid-in capital of $26.03M in Q1 2026.
- How has Profound Medical's additional paid-in capital changed year-over-year?
- Profound Medical's additional paid-in capital increased by 17.3% year-over-year, from $22.2M to $26.03M.
- What is the long-term trend for Profound Medical's additional paid-in capital?
- Over 2 years (2023 to 2025), Profound Medical's additional paid-in capital has grown at a 10.3% compound annual growth rate (CAGR), from $20.81M to $25.31M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.